Abstract
The inhibitory activity of eight antibiotics and the inhibitory and bactericidal activities of combinations of trimethoprim/sulfamethoxazole (TMP/SMX) plus three fixed concentrations of polymyxin B (0.01 μg/ml, 0.1 μg/ml and 0.5 μg/ml) against 30 multiresistant strains ofStenotrophomonas maltophilia were tested. Polymyxin B at 0.01 μg/ml modified the inhibitory activity of TMP/SMX against only 40% of strains. At 0.1 μg/ml and 0.5 μg/ml, polymyxin B enhanced the inhibitory activity of TMP/SMX activity against all strains. Polymyxin B enhanced the bactericidal activity of TMP/SMX only at concentrations near the minimum inhibitory concentration of polymyxin B alone.
Similar content being viewed by others
References
Holmes B, Lapage SP, Easterling BG: Distribution in clinical material and identification ofPseudomonas maltophilia. Journal of Clinical Pathology 1979, 32: 62–72.
Elting LS, Khardori N, Bodey GP, Fainstein V: Nosocomial infection caused byXanthomonas maltophilia: a case-control study of predisposing factors. Infection Control and Hospital Epidemiology 1990, 11: 134–138.
Khardori N, Elting L, Wong E, Schable B, Bodey GP: Nosocomial infections due toXanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Reviews of Infectious Diseases 1990, 12: 997–1003.
Garcia-Rodríguez JA, Garcia Sanchez JE, Garcia Garcia Ml, Garcia Sanchez E; Muñoz Bellido JL: Antibiotic susceptibility profile ofXanthomonas maltophilia in vitro activity of β-lactam/β-lactamase inhibitor combinations. Diagnostic Microbiology and Infectious Disease 1991, 14: 239–243.
Bonfiglio G, Livermore DM: Effect of media composition on the susceptibility ofXanthomonas maltophilia to β-lactam antibiotics. Journal of Antimicrobial Chemotherapy 1991, 28: 837–842.
Pankuch GA, Jacobs MR, Rittenhouse SF, Appelbaum PC: Susceptibilities of 123 strains ofXanthomonas maltophilia to eight β-lactams (including β-lactam/β-lactamase inhibitor combinations) and ciprofloxacin tested by five methods. Antimicrobial Agents and Chemotherapy 1994, 38: 2317–2333.
Neu HC, Saha G, Chin NX: Resistance ofXanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors. Diagnostic Microbiology and Infectious Disease 1989, 12: 283–285.
Felegie TP, Yu VL, Rumans LW, Yee RB: Susceptibility ofPseudomonas maltophilia to antimicrobial agents, singly and in combination. Antimicrobial Agents and Chemotherapy 1979, 16: 833–837.
Poulos CD, Matsumura SO, Willey BM, Low DE, McGeer A: In vitro activities of antimicrobial combinations againstStenotrophomonas (Xanthomonas) maltophilia. Antimicrobial Agents and Chemotherapy 1995, 39: 2220–2223.
Chow AW, Wong J, Bartlett KH: Synergistic interactions of ciprofloxacin and extended-spectrum β-lactams or aminogiycosides against multiply drug-resistantPseudomonas maltophilia. Antimicrobial Agents and Chemotherapy 1988, 32: 782–784.
Yu VL, Felegie TP, Yee RB, Pasculle AW, Taylor FH: Synergistic interactions in vitro with use of three antibiotics simultaneously againstPseudomonas maltophilia. Journal of Infectious Diseases 1980, 142: 602–607.
Rosenblatt JE, Stewart PR: Combined activity of sulfamethoxazole, trimethoprim and polymyxin B against gram-negative bacilli. Antimicrobial Agents and Chemotherapy 1974, 6: 84–92.
National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. NCCLS, Villanova, PA, 1994.
Vartivarian SE, Anaissie E, Bodey G, Sprigg H, Rolston K: A changing pattern of susceptibility ofXanthomonas maltophilia to antimicrobial agents: implications for therapy, Antimicrobial Agents and Chemotherapy 1994, 38: 624–627.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Muñoz, J.L., García, M.I., Muñoz, S. et al. Activity of trimethoprim/ sulfamethoxazole plus polymyxin B against multiresistantStenotrophomonas maltophilia . Eur. J. Clin. Microbiol. Infect. Dis. 15, 879–882 (1996). https://doi.org/10.1007/BF01691222
Issue Date:
DOI: https://doi.org/10.1007/BF01691222